REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 32 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q3 2023. The put-call ratio across all filers is 1.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $613 | +638.6% | 123,915 | +1294.3% | 0.45% | +603.1% |
| Q2 2023 | $83 | -83.9% | 8,887 | -92.8% | 0.06% | -85.3% |
| Q1 2023 | $517 | -1.9% | 123,915 | 0.0% | 0.44% | -8.0% |
| Q4 2022 | $527 | -99.8% | 123,915 | +125.0% | 0.47% | +86.2% |
| Q3 2022 | $275,000 | +343.5% | 55,078 | 0.0% | 0.25% | +379.2% |
| Q2 2022 | $62,000 | -54.1% | 55,078 | 0.0% | 0.05% | -45.4% |
| Q1 2022 | $135,000 | -15.1% | 55,078 | 0.0% | 0.10% | +12.8% |
| Q4 2021 | $159,000 | -40.0% | 55,078 | -27.4% | 0.09% | -41.9% |
| Q3 2021 | $265,000 | +3.1% | 75,835 | 0.0% | 0.15% | +1.4% |
| Q2 2021 | $257,000 | -40.9% | 75,835 | 0.0% | 0.15% | -52.9% |
| Q1 2021 | $435,000 | – | 75,835 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 564,000 | $2,752,320 | 0.84% |
| EMC Capital Management | 123,915 | $613 | 0.45% |
| Ikarian Capital, LLC | 5,095 | $2,486,360 | 0.30% |
| SABBY MANAGEMENT, LLC | 44,593 | $217,614 | 0.16% |
| ARMISTICE CAPITAL, LLC | 600,000 | $2,928,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 70,181 | $342 | 0.03% |
| Caption Management, LLC | 275,200 | $1,342,976 | 0.02% |
| Caption Management, LLC | 216,600 | $1,057,008 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 109,700 | $535,336 | 0.01% |
| J. Goldman & Co LP | 75,000 | $366,000 | 0.01% |